Sentences with phrase «generic drugmaker»
A "generic drugmaker" refers to a company that produces and sells generic drugs. Generic drugs are similar to brand-name drugs, but they are less expensive because they do not have a patent. These companies create affordable versions of medications that are already on the market, once their patent has expired. Full definition
FRANKFURT U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group cancelled their $ 4.75 billion (3.4 billion pounds) takeover agreement.
reuters.com
** U.S. generic drugmaker Akorn < AKRX.O > is taking former suitor Fresenius to court after the German healthcare group cancelled their $ 4.75 billion takeover agreement.
Valeant (vrx) said on Monday that Papa, the former head of generic drugmaker Perrigo, would replace Michael Pearson as its CEO.
The Lake Forest - based generic drugmaker alleges in a suit that the German medical equipment giant used a false pretext to walk away from their acquisition agreement.
Teva, the world's biggest generics drugmaker, issues first - quarter results on Thursday and investors will be looking for any new information from the company regarding the expected timing of fremanezumab approval, and any progress in paying down its hefty debt and its cost - cutting measures.
Still, analysts have been expecting more M&A among generic drugmakers as the entire pharmaceutical industry has been consolidating rapidly in the past couple of years.
Martin Sass, whose firm, M.D. Sass, manages $ 7.5 billion, admits that he prefers pharmaceutical companies such as Shire (SHPG) and Actavis (ACT) that are fleshing out their pipelines by snapping up competitors, as well as generic drugmaker Mylan (MYL), which he hopes will give in to Teva Pharmaceuticals» (TEVA) takeover offer.
(Reuters)- German healthcare conglomerate Fresenius SE & Co KGaA (FREG.DE) is close to acquiring generic drugmaker Akorn Inc (AKRX.O) in an all - cash deal valuing the company at more than $ 4 billion, people familiar with the matter said on Monday.
Indian generic drugmakers currently produce nearly 40 percent of generic drugs and over-the-counter products and 10 percent of finished dosages used in the United States.
• Fresenius SE & Co KGaA (DB: FRE) is close to acquiring Akorn (Nasdaq: AKRX), a Lake Forest, Ill. - based generic drugmaker, in an all - cash deal valuing the company at more than $ 4 billion, according to Reuters.
Since last August, the world's biggest generics drugmaker has seen its share price fall over 40 percent due to a decline in U.S. generic drug prices and copycat competition for its blockbuster multiple sclerosis drug Copaxone.
FRANKFURT U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $ 4.75 billion takeover agreement.
The four companies that challenged the Restasis patents include Teva Pharmaceuticals, the world's largest generic drugmaker, as well as Mylan Pharmaceuticals, Apotex, and Akorn.
Generic drugmaker Mylan has proposed buying Perrigo for about $ 29 billion in cash and stock in what would be the biggest pharmaceutical deal of the year so far.
Last month, Fresenius SE & Co KGaA (FREG.DE) agreed to acquire generic drugmaker Akorn Inc AKRX.N for $ 4.3 billion.
FRANKFURT (Reuters)- U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $ 4.75 billion takeover agreement.
German health - care group Fresenius said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drugmaker.
Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $ 5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill. - based generic drugmaker.
Akorn Inc. (AKRX) shares plunged the most since February in Monday after Germany's Fresenius Medical Care (FSNUY) dropped its planned $ 5 billion takeover of the generic drugmaker after a probe into possible data breaches by the U.S. Food & Drug Administration.
Akorn — German drugmaker Fresenius pulled out its $ 4.75 billion deal to buy the U.S. generic drugmaker, saying it had found «material breaches» of Food and Drug Administration data integrity requirements at Akorn.
Hikma Pharmaceuticals plc (HKMPY) shares were an early mover of note, falling more than 5 % to a year - to - date low of 1,616 pence each after the generic drugmaker lowered its full year revenue guidance Friday after the U.S. Food & Drug Administration expressed concern over its generic Advair Diskus product.
Teva Pharmaceuticals, the world's biggest generic drugmaker, could be preparing major cuts to its 6,800 - strong U.S. workforce amid slumping profits and falling prices.
Mylan NV Executive Chairman Robert Coury was named chairman of the generic drugmaker's board in a move that reduces his role in management of the company and could give Heather Bresch greater responsibilities as chief executive.
That guaranteed the generic drugmaker would have no competition, and so could keep prices high, for at least six months.
It's the first so - called «pay for delay» case brought by the commission in which a drug's original maker agreed not to sell its own «authorized generic» version until well after a generic drugmaker began selling its product.
In an effort to extend the protection, Sanofi obtained a series of patents for other indications, which were challenged by Apotex, a generic drugmaker.